Extracted algorithm research record
ViprasolMACrossEA
EMA crossover with trailing stop, break-even, ADX/RSI/session/spread filters, dual money-management modes, a daily trade cap, and an on-chart dashboard.
Source & extraction context
Evidence label: source_code (source claim, not independent verification). Recorded completeness: 80.0/100. Neither is a performance result.
Names identify source records. Inclusion is not an endorsement or a claim of authorship, ownership or reuse permission. Check the source license before reusing any implementation.
Extraction warnings
No automated warnings are recorded in this snapshot. This does not establish that the extraction or system is sound.
Recorded market & execution profile
- Recorded markets
- any
- Recorded timeframes
- M15, H1
- Recorded sessions
- server time, 07:00-20:00 GMT (midnight-wrap supported)
- Recorded regime
- any
Recorded indicators & parameters
| Indicator | Parameters | Applied to |
|---|---|---|
| EMA | {"period": 12} | close |
| EMA | {"period": 26} | close |
Extracted strategy rules
Recorded long-entry rules
- EMA(12) crosses above EMA(26)
Recorded short-entry rules
- EMA(12) crosses below EMA(26)
Recorded exit rules
- Close on opposite EMA cross
- Break-even move if enabled
- Trailing stop if enabled
Recorded filters
- ADX trend filter with minimum level of 20
- RSI confirmation with overbought level of 70 and oversold level of 30
- Spread filter with max spread of 30 points
- Session filter with trading window from 07:00 to 20:00 GMT (midnight-wrap supported)
- Stop loss
- Stop loss is set at 2.0 ATR
- Take profit
- Take profit is set at 3.0 ATR
- Position sizing
- Fixed lot or risk percent of equity, with a hard lot cap
Questions about this record
What entry rules are recorded for ViprasolMACrossEA?
Long: EMA(12) crosses above EMA(26) Short: EMA(12) crosses below EMA(26) These are unverified extracted rules.
Which markets and timeframes are recorded?
Markets: any. Timeframes: M15, H1. These are source-recorded labels, not verified execution behavior.